**Core Concept**
The Quadrivalent Meningococcal Conjugate (MenACWY) vaccine is designed to protect against four serogroups of Neisseria meningitidis, which are A, C, W, and Y. This vaccine is widely used in various countries to prevent invasive meningococcal disease. However, Serotype B is not included in this quadrivalent vaccine due to the lack of a suitable conjugate vaccine available at the time of its development.

**Why the Correct Answer is Right**
Serotype B is a significant cause of meningococcal disease, particularly among adolescents and young adults. The reason why the quadrivalent MenACWY vaccine does not cover Serotype B is that it was difficult to develop a conjugate vaccine for Serotype B. Conjugate vaccines work by linking a weakened form of the bacteria's sugar coating to a carrier protein, which helps the body recognize and remember the bacteria. For Serotype B, the available conjugate vaccines were not effective or safe for use, so the MenACWY vaccine does not cover this serotype.

**Why Each Wrong Option is Incorrect**
**Option A:** Serotype A is one of the serotypes covered by the quadrivalent MenACWY vaccine, making it a wrong choice.
**Option C:** Serotype C is also covered by the quadrivalent MenACWY vaccine, which makes it an incorrect option.
**Option D:** Serotype Y is another serotype included in the quadrivalent MenACWY vaccine, making it an incorrect choice as well.

**Clinical Pearl / High-Yield Fact**
When considering meningococcal vaccination, it's essential to remember that the MenB vaccine, which covers Serotype B, is a separate vaccine from MenACWY and is recommended for individuals at high risk of meningococcal disease, such as those with certain underlying medical conditions or those who are traveling to areas with high meningococcal disease rates.

**✓ Correct Answer: B. Serotype B**